Zacks: Analysts Anticipate The Clorox Company (CLX) Will Post Earnings of $1.30 Per Share

Equities analysts forecast that The Clorox Company (NYSE:CLX) will announce $1.30 earnings per share for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for The Clorox’s earnings, with the highest EPS estimate coming in at $1.34 and the lowest estimate coming in at $1.28. The Clorox reported earnings per share of $1.31 in the same quarter last year, which would indicate a negative year-over-year growth rate of 0.8%. The business is scheduled to announce its next earnings results before the market opens on Wednesday, May 2nd.

According to Zacks, analysts expect that The Clorox will report full-year earnings of $6.19 per share for the current fiscal year, with EPS estimates ranging from $6.10 to $6.28. For the next fiscal year, analysts anticipate that the business will report earnings of $6.47 per share, with EPS estimates ranging from $6.14 to $6.63. Zacks’ earnings per share averages are an average based on a survey of sell-side analysts that follow The Clorox.

How to Become a New Pot Stock Millionaire

The Clorox (NYSE:CLX) last issued its quarterly earnings results on Friday, February 2nd. The company reported $1.23 EPS for the quarter, topping the Zacks’ consensus estimate of $1.22 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.43 billion. The Clorox had a return on equity of 126.70% and a net margin of 13.21%. The Clorox’s quarterly revenue was up .7% compared to the same quarter last year. During the same period last year, the company posted $1.14 earnings per share.

A number of analysts recently commented on the company. Zacks Investment Research lowered The Clorox from a “hold” rating to a “sell” rating in a report on Monday, April 9th. Barclays set a $131.00 target price on The Clorox and gave the company a “hold” rating in a research note on Friday, April 6th. Morgan Stanley lowered their target price on The Clorox from $133.00 to $128.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 5th. BMO Capital Markets set a $147.00 target price on The Clorox and gave the company a “buy” rating in a research note on Thursday, March 29th. Finally, JPMorgan Chase restated a “neutral” rating and issued a $138.00 target price (down from $139.00) on shares of The Clorox in a research note on Tuesday, March 13th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $136.19.

Large investors have recently added to or reduced their stakes in the stock. Vident Investment Advisory LLC bought a new stake in shares of The Clorox during the 3rd quarter valued at $1,477,000. Allianz Asset Management GmbH raised its stake in shares of The Clorox by 417.8% during the 3rd quarter. Allianz Asset Management GmbH now owns 63,868 shares of the company’s stock valued at $8,425,000 after purchasing an additional 51,534 shares during the period. Jensen Investment Management Inc. raised its stake in shares of The Clorox by 12.1% during the 4th quarter. Jensen Investment Management Inc. now owns 40,960 shares of the company’s stock valued at $6,092,000 after purchasing an additional 4,435 shares during the period. Spearhead Capital Advisors LLC bought a new stake in shares of The Clorox during the 4th quarter valued at $2,846,000. Finally, Advisor Group Inc. raised its stake in shares of The Clorox by 26.8% during the 4th quarter. Advisor Group Inc. now owns 48,896 shares of the company’s stock valued at $7,276,000 after purchasing an additional 10,335 shares during the period. Institutional investors own 75.63% of the company’s stock.

The Clorox stock traded down $0.60 during mid-day trading on Thursday, reaching $126.57. 414,333 shares of the company’s stock were exchanged, compared to its average volume of 1,088,418. The firm has a market capitalization of $16,244.08, a P/E ratio of 23.61, a price-to-earnings-growth ratio of 2.67 and a beta of 0.35. The Clorox has a one year low of $123.64 and a one year high of $150.40. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.35.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Investors of record on Wednesday, April 25th will be paid a dividend of $0.96 per share. This represents a $3.84 dividend on an annualized basis and a dividend yield of 3.03%. This is a positive change from The Clorox’s previous quarterly dividend of $0.84. The ex-dividend date is Tuesday, April 24th. The Clorox’s payout ratio is presently 62.80%.

ILLEGAL ACTIVITY WARNING: “Zacks: Analysts Anticipate The Clorox Company (CLX) Will Post Earnings of $1.30 Per Share” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://ledgergazette.com/2018/04/17/zacks-analysts-anticipate-the-clorox-company-clx-will-post-earnings-of-1-30-per-share.html.

About The Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Get a free copy of the Zacks research report on The Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply